Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

The Role of PYY in Pancreatic Islet Physiology and Surgical Control of Diabetes
Claudia Guida, Sam D. Stephen, Romain Guitton, et al.
Trends in Endocrinology and Metabolism (2017) Vol. 28, Iss. 8, pp. 626-636
Open Access | Times Cited: 36

Showing 1-25 of 36 citing articles:

SCFAs strongly stimulate PYY production in human enteroendocrine cells
Pierre Larraufie, Camille Martin‐Gallausiaux, Nicolas Lapaque, et al.
Scientific Reports (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 344
Mechanisms underlying the weight loss effects of RYGB and SG: similar, yet different
Andrea Pucci, Rachel L. Batterham
Journal of Endocrinological Investigation (2018) Vol. 42, Iss. 2, pp. 117-128
Open Access | Times Cited: 183
Cyclocarya paliurus polysaccharides alleviate type 2 diabetic symptoms by modulating gut microbiota and short-chain fatty acids
Ye Yao, Lijing L. Yan, Han Chen, et al.
Phytomedicine (2020) Vol. 77, pp. 153268-153268
Closed Access | Times Cited: 176
Effect of Bariatric Surgery on Metabolic Diseases and Underlying Mechanisms
Yu Ji, Hangil Lee, Shawn Kaura, et al.
Biomolecules (2021) Vol. 11, Iss. 11, pp. 1582-1582
Open Access | Times Cited: 67
Fecal fermentation and high-fat diet-induced obesity mouse model confirmed exopolysaccharide from Weissella cibaria PFY06 can ameliorate obesity by regulating the gut microbiota
Yinzhuo Xie, Fangyi Pei, Yuchao Liu, et al.
Carbohydrate Polymers (2023) Vol. 318, pp. 121122-121122
Closed Access | Times Cited: 27
Glucagon-like peptide-1 analogs: Miracle drugs are blooming?
Binbin Gong, Zhihong Yao, Chenxu Zhou, et al.
European Journal of Medicinal Chemistry (2024) Vol. 269, pp. 116342-116342
Closed Access | Times Cited: 10
Dipeptidyl Peptidase-4 at the Interface Between Inflammation and Metabolism
Natasha A. Trzaskalski, Evgenia Fadzeyeva, Erin E. Mulvihill
Clinical Medicine Insights Endocrinology and Diabetes (2020) Vol. 13, pp. 117955142091297-117955142091297
Open Access | Times Cited: 68
Dissecting the Physiology and Pathophysiology of Glucagon-Like Peptide-1
Silvano Paternoster, Marco Falasca
Frontiers in Endocrinology (2018) Vol. 9
Open Access | Times Cited: 65
Therapeutic potential of non-starch polysaccharides on type 2 diabetes: from hypoglycemic mechanism to clinical trials
Meng Xiao, Xing Jia, Nifei Wang, et al.
Critical Reviews in Food Science and Nutrition (2022) Vol. 64, Iss. 4, pp. 1177-1210
Closed Access | Times Cited: 27
A peptide triple agonist of GLP-1, neuropeptide Y1, and neuropeptide Y2 receptors promotes glycemic control and weight loss
Kylie S. Chichura, Clinton Elfers, Therese S. Salameh, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 16
Peptides in the regulation of glucagon secretion
Daniel B. Andersen, Jens J. Holst
Peptides (2021) Vol. 148, pp. 170683-170683
Open Access | Times Cited: 32
Design and Evaluation of Peptide Dual-Agonists of GLP-1 and NPY2 Receptors for Glucoregulation and Weight Loss with Mitigated Nausea and Emesis
Brandon T. Milliken, Clinton Elfers, Oleg G. Chepurny, et al.
Journal of Medicinal Chemistry (2021) Vol. 64, Iss. 2, pp. 1127-1138
Open Access | Times Cited: 31
Differential Diagnosis of Post Pancreatitis Diabetes Mellitus Based on Pancreatic and Gut Hormone Characteristics
Yingqi Lv, Xuejia Lu, Gaifang Liu, et al.
The Journal of Clinical Endocrinology & Metabolism (2024) Vol. 109, Iss. 8, pp. 2003-2011
Open Access | Times Cited: 4
Vinegar-processed Schisandra chinensis polysaccharide ameliorates type 2 diabetes via modulation serum metabolic profiles, gut microbiota, and fecal SCFAs
Xingyu Guo, Yang Su, Yongqiang Du, et al.
International Journal of Biological Macromolecules (2025) Vol. 294, pp. 139514-139514
Closed Access
PYY, a Therapeutic Option for Type 2 Diabetes?
Claudia Guida, Reshma Ramracheya
Clinical Medicine Insights Endocrinology and Diabetes (2020) Vol. 13, pp. 117955141989298-117955141989298
Open Access | Times Cited: 27
Positive Effects of NPY1 Receptor Activation on Islet Structure Are Driven by Pancreatic Alpha- and Beta-Cell Transdifferentiation in Diabetic Mice
Ryan A. Lafferty, Neil Tanday, R. Charlotte Moffett, et al.
Frontiers in Endocrinology (2021) Vol. 12
Open Access | Times Cited: 21
Peptide YY (1–36) peptides from phylogenetically ancient fish targeting mammalian neuropeptide Y1 receptors demonstrate potent effects on pancreatic β‐cell function, growth and survival
Ryan A. Lafferty, Neil Tanday, Andrew McCloskey, et al.
Diabetes Obesity and Metabolism (2019) Vol. 22, Iss. 3, pp. 404-416
Open Access | Times Cited: 23
Neuropeptide Y1 receptor antagonism protects β-cells and improves glycemic control in type 2 diabetes
Chieh-Hsin Yang, Danise Ann-Onda, Xuzhu Lin, et al.
Molecular Metabolism (2021) Vol. 55, pp. 101413-101413
Open Access | Times Cited: 13
Development and characterisation of a peptidergic N-and C-terminally stabilised mammalian NPY1R agonist which protects against diabetes induction
Ryan A. Lafferty, Neil Tanday, Peter R. Flatt, et al.
Biochimica et Biophysica Acta (BBA) - General Subjects (2020) Vol. 1864, Iss. 5, pp. 129543-129543
Open Access | Times Cited: 14
Bariatric surgery for diabetic comorbidities: A focus on hepatic, cardiac and renal fibrosis
Huanxin Ding, Yun Zhang, Xiaomin Ma, et al.
Frontiers in Pharmacology (2022) Vol. 13
Open Access | Times Cited: 9
Sleeve Gastrectomy Efficacy on Metabolic and Cardiovascular Dysfunction With a Focus on the Role of Comorbidities
Maria Anastasia Ricci, Stefano Ministrini, Stefano De Vuono, et al.
Angiology (2017) Vol. 69, Iss. 6, pp. 475-482
Closed Access | Times Cited: 13
Peptides from Natural or Rationally Designed Sources Can Be Used in Overweight, Obesity, and Type 2 Diabetes Therapies
Mayara C. F. Gewehr, Renata Silvério, José Cesar Rosa Neto, et al.
Molecules (2020) Vol. 25, Iss. 5, pp. 1093-1093
Open Access | Times Cited: 11
The Potential Mechanism of Remission in Type 2 Diabetes Mellitus After Vertical Sleeve Gastrectomy
Rongfei Wang, Salamu Mijiti, Qilin Xu, et al.
Obesity Surgery (2024) Vol. 34, Iss. 8, pp. 3071-3083
Closed Access | Times Cited: 1
Predictive Model of Type 2 Diabetes Remission after Metabolic Surgery in Chinese Patients
Yufang Luo, Zi Guo, Honghui He, et al.
International Journal of Endocrinology (2020) Vol. 2020, pp. 1-13
Open Access | Times Cited: 10
Theoretical study of the interactions between peptide tyrosine tyrosine [PYY (1-36)], a newly identified modulator in type 2 diabetes pathophysiology, with receptors NPY1R and NPY4R
Yee Siew Choong, Yee Ying Lim, Jia Xin Soong, et al.
HORMONES (2021)
Closed Access | Times Cited: 9
Page 1 - Next Page

Scroll to top